Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
We provide 1 form of Miglustat
Miglustat
72599-27-0
|
219.147
|
0.906
Miglustat is an inhibitor of glucosylceramide synthase. It is used for the management of mild to moderate type I Gaucher disease for patients who are not candidates for whole enzyme replacement.
1,5-(butylimino)-1,5-dideoxy-D-glucitol | Miglustat | N-Butyl-1-deoxynojirimycin | N-butyl 1,5-dideoxy-1,5-imino-D-glucitol | N-butyl-deoxygalactonojirimycin | N-butyldeoxynojirimycin | NB-DNJ | zavesca
Miglustat is an inhibitor of glucosylceramide synthase. It is used for the management of mild to moderate type I Gaucher disease for patients who are not candidates for whole enzyme replacement.
1,5-(butylimino)-1,5-dideoxy-D-glucitol | Miglustat | N-Butyl-1-deoxynojirimycin | N-butyl 1,5-dideoxy-1,5-imino-D-glucitol | N-butyl-deoxygalactonojirimycin | N-butyldeoxynojirimycin | NB-DNJ | zavesca
$320/5 mg
(EBC)
1
CAS:441061-44-5
0
CAS:2159078-06-3
0
CAS:210110-90-0
(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride
(2R,3R,4R,5S)-1-b...
0
CAS:875766-12-4
0
CAS:155501-85-2
0
CAS:305379-00-4
0
CAS:141206-42-0
0
We provide 0 compound for Miglustat